Marketing Manager - Lung Cancer (Finland) – Nordic Marketing Company

Are you ready to turn cutting-edge science into meaningful outcomes for people living with lung cancer? Do you see yourself as an innovator ready to channel your ambition into a company that follows the science to deliver life‑changing medicines? AstraZeneca could be the place for you.   Our AstraZeneca Nordic Marketing Company employs around 550 people and has offices located in Copenhagen, Stockholm, Oslo, and Espoo. AstraZeneca Nordic is a recognized leader in its core therapy areas and aims to improve the lives of millions of people. This is an area where you are free to be more – you are encouraged to challenge traditional ways and test your curiosity. We drive innovative science, deliver key launches, build close collaboration and partnerships within health care.  About the Role As Marketing Manager for Lung Cancer, you will own the country strategy and execution for assigned brands across the lung cancer portfolio. You will translate global direction into locally relevant plans grounded in patient journeys, market insights and data. Your leadership will drive launch excellence, strengthen customer engagement through omnichannel campaigns and accelerate adoption across the product lifecycle. You will collaborate closely with cross-functional and field teams to enable confident execution in the field, ensure compliant and timely delivery, and co-create solutions with healthcare stakeholders that improve access and outcomes. This role blends strategic thinking with hands-on delivery, giving you the platform to influence the healthcare ecosystem and deliver measurable business and patient impact. The role is based in Finland. Accountabilities • Finland Brand Leadership : Lead country strategy, launch planning and execution for lung cancer brands based on robust market data, customer insights and patient journeys. • Insight-Driven Planning : Assess market dynamics, brand performance, risks and growth opportunities; translate insights into clear strategic priorities and resource choices. • Localization of Global Strategy : Adapt global strategies and deliverables to country requirements while maintaining alignment with regional and global direction. • Omnichannel Campaign Design and Execution : Design, implement and continuously improve integrated campaigns, materials and channel mixes across the product lifecycle to drive adoption, adherence and persistence. • Performance Optimization : Use performance data and market research to evaluate impact, optimize activities and inform evidence-based commercial decisions. • Compliance and Quality: Ensure timely, high-quality delivery in accordance with procedures, legal requirements, ethical rules and internal standards. • Cross-Functional and Field Enablement : Lead and inspire the cross-functional brand team, create clarity on priorities and equip field teams with training, tools and effective role-to-role communication. • Stakeholder Collaboration and Risk Management: Identify and address obstacles, risks and opportunities across internal and external collaborations to keep execution on track. • External Engagement and Healthcare Solutions : Maintain an active external focus (approximately 20%) to generate healthcare-system and customer insights, test strategic assumptions, and co-create innovative solutions that improve engagement, access to medicines and outcomes for patients; engage healthcare stakeholders in appropriate scientific and strategic dialogue in coordination with Medical, Market Access and field colleagues. • Therapy-Area Contribution and Alliances : Act as an ambassador for lung cancer brands, contribute to cross-disease initiatives and collaborate with alliance partners and regional/global colleagues on strategy, launches, materials and implementation to